31-12-291

A 12-week, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults with Schizophrenia

Study Information Study ID

31-12-291/NCT01663532/EudraCT2012-003805-86

Full Study Title

A 12-week, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults with Schizophrenia

Active Ingredient / Drug Information

Aripiprazole/Injectable suspension

Disease

Schizophrenia

Phase

CSR Summary

31-12-291 Clinical Summary.pdf